Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma
The study provided new ideas for the development and clinical application of Bufonis venenum related formulation and offered new drug for the treatment of HCC.
Authors
- Siqi Yang (ORCID: https://orcid.org/0009-0000-3057-1160)
- Jinshuai Lan (ORCID: https://orcid.org/0000-0003-1926-2062)
- Ming Li (ORCID: https://orcid.org/0000-0002-9242-7735)
- Zhe Li (ORCID: https://orcid.org/0000-0003-3738-4418)
- Yue Ding (ORCID: https://orcid.org/0000-0002-2911-1244)
- Liyan Sun (ORCID: https://orcid.org/0000-0002-2324-3318)
- Tong Zhang (ORCID: https://orcid.org/0000-0002-2442-8613)
- Ya Wu
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-25
- DOI
- https://doi.org/10.3389/fphar.2024.1486742
- Citations
- 1
- Primary Topic
- Bioactive Compounds and Antitumor Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.35
Funders
- Natural Science Foundation of Shanghai
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- China Postdoctoral Science Foundation
- Shanghai Education Development Foundation
- Shanghai Municipal Education Commission
- Shanghai University of Traditional Chinese Medicine
- Shanghai Institute of Ceramics, Chinese Academy of Sciences
- National Key Research and Development Program of China
- Program of Shanghai Academic Research Leader
- Shanghai Shuguang Program
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission